Soreijia Fama
4597.TTSE GROWTHPharmaceutical
Filed as Solasia Pharma K.K. (2022-08–2026-08)
Financials · Consolidated
| Fiscal year ended | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|---|
| Revenue | ¥429m | ¥316m | ¥617m | ¥1.1bn | ¥559m | ¥454m |
| Operating income | −¥861m | −¥2.0bn | −¥1.1bn | −¥2.5bn | −¥2.4bn | — |
| Net income (owners) | −¥876m | −¥1.9bn | −¥1.1bn | −¥2.5bn | −¥2.5bn | −¥4.1bn |
| Total assets | ¥2.1bn | ¥1.4bn | ¥2.2bn | ¥3.1bn | ¥3.1bn | ¥5.8bn |
| Net assets / equity | ¥1.8bn | ¥1.2bn | ¥1.9bn | ¥2.7bn | ¥2.6bn | ¥3.7bn |
| Operating cash flow | −¥847m | −¥1.0bn | −¥359m | −¥2.1bn | −¥2.5bn | −¥2.8bn |
| EPS (basic) | ¥-3.69 | ¥-9.77 | ¥-6.62 | ¥-16.77 | ¥-19.04 | ¥-35.16 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 4
| Period | Form | Figures |
|---|---|---|
| 2022-01-01 → 2022-12-31 | Annual | 187 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 100 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2Amended | 100 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 100 figures · EDINET |
23 more reports are still being processed.